Please check your internet connection and try again.
# Daidzein + Genistein + Palmitoylethanolamide
## Overview
This combination product contains the isoflavones daidzein and genistein, found in soy, and palmitoylethanolamide (PEA), an endogenous fatty acid amide. These compounds are often marketed as dietary supplements for various health conditions, including pain and inflammation.
## Primary Indications
There are no FDA-approved indications for this combination product. It is typically used off-label for the management of:
* Pain, particularly neuropathic pain.
* Inflammatory conditions.
* Menopausal symptoms (though evidence is limited and conflicting).
## Adult Dosing
Dosing for this combination is not standardized and varies widely. Common regimens for PEA (often combined with isoflavones) range from **300 mg to 1200 mg daily**, often divided into 1-3 doses. Daidzein and genistein doses in supplements typically range from **20 mg to 100 mg** total per day.
* **Specific dosing depends on the product formulation and the condition being treated.**
* **Consult product labeling or specific clinical protocols for precise dosing.**
## Pediatric Dosing
No established pediatric dosing exists for this combination product. Safety and efficacy in pediatric populations have not been studied.
## Dose Adjustments
No specific dose adjustments are established for renal or hepatic impairment due to the lack of regulatory approval and standardized dosing.
## Contraindications
* Hypersensitivity to any component of the product.
* Pregnancy and breastfeeding (due to limited safety data).
* Individuals with hormone-sensitive cancers (e.g., breast, uterine, ovarian cancer) should use with caution due to the estrogenic potential of isoflavones, though evidence is complex and debated.
## Adverse Effects
Adverse effects are generally mild and may include:
* Gastrointestinal upset (nausea, bloating, diarrhea).
* Headache.
* Rash.
## Key Drug Interactions
* **Hormone-sensitive medications:** The estrogenic effects of daidzein and genistein may theoretically interact with hormone replacement therapy, oral contraceptives, or other medications affecting hormone levels.
* **Anticoagulants/Antiplatelets:** Isoflavones may have mild antiplatelet effects, though clinical significance is unclear. Monitor for increased bleeding risk if used concurrently with anticoagulants (e.g., warfarin, heparin) or antiplatelet agents (e.g., aspirin, clopidogrel).
## Monitoring
* Monitor for efficacy in managing the intended condition (e.g., pain reduction, symptom improvement).
* Monitor for any new or worsening adverse effects.
* For individuals with hormone-sensitive conditions, discuss any concerns with their oncologist.
## Clinical Pearls
* This combination is considered a dietary supplement, not a pharmaceutical drug. Quality and purity can vary significantly between manufacturers.
* The efficacy of isoflavones, particularly for menopausal symptoms, is a subject of ongoing research with mixed results.
* PEA's mechanism of action is thought to involve interaction with the endocannabinoid system and PPAR-alpha, contributing to anti-inflammatory and analgesic effects.
---
**Disclaimer:** This information is for educational purposes only and does not substitute for professional medical advice. Always consult with a qualified healthcare provider to determine if this medication is appropriate for your needs and to discuss any potential risks and benefits. Verify current prescribing information with the manufacturer's package insert or other standard reference sources.
